Clinical Trial Update: Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation [Phase 3]

View source ↗

Summary

Phase 3 trial assessing ribavirin with or without monoclonal antibody therapy for RSV pneumonia in cancer patients after peripheral stem cell transplantation ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Respiratory Syncytial Virus Infection
• Rsv Pneumonia

Drugs mentioned

• Monoclonal antibody therapy
• Ribavirin (ribavirin)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Cancer | Phase 3 | Status: COMPLETED